Persons with both opioid use disorder (OUD) and alcohol use disorder have been understudied. The researchers in this study investigated whether OUD medications are associated with decreased risk in alcohol-related morbidity.
The study authors investigated the prevalence and correlates of medical use and misuse of psychoactive prescription medications in youth and young adults in the United States.
System deployed in 2,444 patients during 16-month period showed that 61 percent of opioid tablets remained unused
Mean opioid consumption is increased 24 months after an episode of critical care.
To learn more about the overlapping crises of the opioid epidemic and the COVID-19 pandemic, Psychiatry Advisor interviewed pain specialist Paul J. Christo, MD, MBA, the Director of the Multidisciplinary Pain Fellowship Program at Johns Hopkins Hospital in Baltimore, Maryland.
While the use of TIRF medications has declined in recent years, data have suggested that prescribing of these drugs to patients who are not opioid tolerant still remains.
Researchers found a relationship between pain-related anxiety with pain intensity, interference, and the potential for opioid overuse.
As the diagnosis of opioid use disorder is often delayed or missed altogether, the researchers sought to test the utility of machine learning in creating a prediction model and algorithm for early diagnosis of OUD.
Patients already receiving opioid use disorder treatment continued to receive care during the early weeks of the COVID-19 pandemic, with some disruption to urine testing.
The number of individuals filling buprenorphine prescriptions for opioid use disorder has plateaued but not decreased during the COVID-19 pandemic.
